- Home
- WATT vs CSCI Comparison
WATT vs CSCI Comparison
Compare WATT & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WATT
- CSCI
- Stock Information
- Founded
- WATT 2012
- CSCI 1990
- Country
- WATT United States
- CSCI Canada
- Employees
- WATT N/A
- CSCI N/A
- Industry
- WATT Radio And Television Broadcasting And Communications Equipment
- CSCI
- Sector
- WATT Technology
- CSCI
- Exchange
- WATT Nasdaq
- CSCI NYSE
- Market Cap
- WATT 9.1M
- CSCI 10.5M
- IPO Year
- WATT 2014
- CSCI 1996
- Fundamental
- Price
- WATT $0.28
- CSCI $3.61
- Analyst Decision
- WATT
- CSCI
- Analyst Count
- WATT 0
- CSCI 0
- Target Price
- WATT N/A
- CSCI N/A
- AVG Volume (30 Days)
- WATT 2.1M
- CSCI 3.3K
- Earning Date
- WATT 05-13-2025
- CSCI 05-13-2025
- Dividend Yield
- WATT N/A
- CSCI N/A
- EPS Growth
- WATT N/A
- CSCI N/A
- EPS
- WATT N/A
- CSCI N/A
- Revenue
- WATT $1,047,000.00
- CSCI $9,030,000.00
- Revenue This Year
- WATT $1,028.91
- CSCI N/A
- Revenue Next Year
- WATT N/A
- CSCI N/A
- P/E Ratio
- WATT N/A
- CSCI N/A
- Revenue Growth
- WATT 137.41
- CSCI 36.51
- 52 Week Low
- WATT $0.12
- CSCI $1.96
- 52 Week High
- WATT $2.70
- CSCI $7.72
- Technical
- Relative Strength Index (RSI)
- WATT 52.41
- CSCI N/A
- Support Level
- WATT $0.27
- CSCI N/A
- Resistance Level
- WATT $0.29
- CSCI N/A
- Average True Range (ATR)
- WATT 0.02
- CSCI 0.00
- MACD
- WATT 0.00
- CSCI 0.00
- Stochastic Oscillator
- WATT 74.50
- CSCI 0.00
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.